New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 6, 2010
May 14, 2020
53827c26-7bc8-4348-a114-e4c7c1bb9ae2
Related Documents
Early Development Considerations for Innovative Combination Products: Guidance for Industry and FDA Staff
Guidance DocumentSeptember 1, 2006Office of the Commissioner
Requesting FDA Feedback on Combination Products : Guidance for Industry and FDA Staff
Guidance DocumentDecember 4, 2020Office of the Commissioner
Postmarketing Safety Reporting for Combination Products: Guidance for Industry and FDA Staff
Guidance DocumentJuly 22, 2019Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox